Back to all Representative Matters
Feb 25, 2022
Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharmaceuticals Corp.
Juno Pharmaceuticals Corp., a Canadian specialty generics pharmaceuticals company, announced that it had received a strategic growth investment from Signet Healthcare Partners, a New York-based healthcare growth equity firm.
These proceeds will support Juno in expanding its complex and high-value generic and biosimilar portfolio and accelerating growth.
Aird & Berlis LLP acted as legal counsel for Juno Pharmaceuticals Corp. with a team including Richard Epstein, Lorway Gosse, Aaron Bains (Corporate/Commercial) and Francesco Gucciardo (Tax).